Bank of Montreal
ASLN

Bank of Montreal’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bank of Montreal’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-750
Closed -$58K – 4973
2020
Q2 		$58K Hold
750
– – ﹤0.01% 3370
2020
Q1 		$30K Buy
750
+500
+200% +$38K ﹤0.01% 3105
2019
Q4 		$20K Buy
+250
New +$17.9K ﹤0.01% 4323

Other funds holding ASLN

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's ASLN Position: Q3 2020 in Review

Bank of Montreal sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2020, closing a stake of 750 shares — an estimated $58K sold.

Bank of Montreal first reported a position in ASLN in Q4 2019 and held it in 3 quarters. The position peaked at $58K in Q2 2020. 7 funds tracked by Wall St. Rank hold ASLN as of Q3 2020.

  • Bank of Montreal reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Bank of Montreal sold 750 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2020, an estimated $58K.
  • Bank of Montreal first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 3 quarters.
  • Bank of Montreal's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $58K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2020.

Based on Bank of Montreal's 13F filing for Q3 2020, filed 12 Nov 2020.